BNO 5.26% 20.0¢ bionomics limited

Technicals looking sick, page-10

  1. 590 Posts.
    lightbulb Created with Sketch. 4
    If you go back to 3D's favourite bit of journalism when they reported on one of the initial agitation patients I believe it was September last year. Which puts the commencement of enrollment at 7 months ago. This means that their enrollment velocity could not be greater than about 1 patient per week (given they aren't at full enrollment). If this is the case and there are no external factors on the trial it's abysmal.

    It's not right to assume external factors but if you look at what's there - the slowest trial enrollment ever, the ptsd results, the 2nd Greenhill review this company has undertaken & I might be wrong on this one but I'm sure something was supposed to happen this quarter (3 days left) with 350 - something seems off.

    Communication is still horrible, there is definitely more to the story. We're being treated like mugs I am not counting on everything being wrapped up with a neat little bow by June.

 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.